NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









smartbax GmbH

smartbax GmbH

Private
MunichHealthcare & Life Scienceshttps://www.smartbax.de/

Last Round

Early Funding

Jun 30, 2026

Total Funding Raised

$16.51M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

smartbax GmbH is a biotechnology company that develops a new generation of antibiotics to address the increasing spread of multidrug-resistant bacteria.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

antimicrobial therapydrug discoveryantibiotic resistanceantibiotic developmentsuperbugsbiotechnologyinfectious diseasesmall-molecule drugspharmaceutical R&Dpreclinical researchdrug pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

smartbax GmbH Comps

Public and private peers based on sector, stage, and business model.

smartbax GmbH comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

smartbax GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJun 30, 2026
Series AOct 22, 2025
SeedMay 23, 2023
Pre SeedApr 1, 2021

Key People

Founding team and executive leadership

Robert Macsics

Co-founder And CEO

Founding Team

smartbax GmbH Investors

Notable investors and investment history

smartbax GmbH investors
InvestorRounds
Boehringer IngelheimSeed
Boehringer Ingelheim Venture FundEarly Funding, Series A, Seed, Pre Seed
Bayern KapitalEarly Funding, Series A
UnternehmertumSeries A
High-Tech GründerfondsEarly Funding, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 30, 2026

    $7M raised with Bayern Kapital leading.

  • Jun 18, 2026

    Monthly visitors grew 3074% MoM, from 23 to 730.

smartbax GmbH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

smartbax GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about smartbax GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersMunich
Employee Range6
Year Founded2021
Last FundingJun 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.